Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus.

Cheema, Amrita K; Kaur, Prabhjit; Fadel, Amina; Younes, Noura; Zirie, Mahmoud; Rizk, Nasser M

Cheema, Amrita K; Kaur, Prabhjit; Fadel, Amina; Younes, Noura; Zirie, Mahmoud; Rizk, Nasser M.

Afiliación

Cheema AK; Department of Oncology, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC, USA.
Kaur P; Department of Oncology, Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, DC, USA.
Fadel A; Biomedical Sciences Department, College of Health Sciences and Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.
Younes N; Clinical Chemistry Lab, Hamad Medical Corporation, Doha, Qatar.
Zirie M; Endocrine Department, Hammad Medical Corporation, Doha, Qatar.
Rizk NM; Biomedical Sciences Department, College of Health Sciences and Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.

Diabetes Metab Syndr Obes ; 13: 2409-2431, 2020.

Article en En | MEDLINE | ID: mdl-32753925

Palabras clave

bioinformatics; biomarkers; disorders; pathway analysis; regulators; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google